TXNIP: A Double-Edged Sword in Disease and Therapeutic Outlook.

Min Pan, Fengping Zhang, Kai Qu, Chang Liu, Jingyao Zhang

Oxidative medicine and cellular longevity 2022

filter terms:

Thioredoxin-interacting protein (TXNIP) was originally named vitamin D3 upregulated protein-1 (VDUP1) because of its ability to bind to thioredoxin (TRX) and inhibit TRX function and expression. TXNIP is an alpha-arrestin protein that is essential for redox homeostasis in the human body. TXNIP may act as a double-edged sword in the cell. The balance of TXNIP is crucial. A study has shown that TXNIP can travel between diverse intracellular locations and bind to different proteins to play different roles under oxidative stress. The primary function of TXNIP is to induce apoptosis or pyroptosis under oxidative stress. TXNIP also inhibits proliferation and migration in cancer cells, although TXNIP levels decrease, and function diminishes in various cancers. In this review, we summarized the main structure, binding proteins, pathways, and the role of TXNIP in diseases, aiming to explore the double-edged sword role of TXNIP, and expect it to be helpful for future treatment using TXNIP as a therapeutic target. Copyright © 2022 Min Pan et al.

Citation

Min Pan, Fengping Zhang, Kai Qu, Chang Liu, Jingyao Zhang. TXNIP: A Double-Edged Sword in Disease and Therapeutic Outlook. Oxidative medicine and cellular longevity. 2022;2022:7805115